• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病:生活方式和生活质量。

Nonalcoholic fatty liver disease: lifestyle and quality of life.

机构信息

80th Battalion of Medical Corps, General Ioannis Makrygiannis Camp, Pyli, Kos, Greece.

First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

出版信息

Hormones (Athens). 2022 Mar;21(1):41-49. doi: 10.1007/s42000-021-00339-6. Epub 2021 Dec 1.

DOI:10.1007/s42000-021-00339-6
PMID:34854066
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder whose current rapidly expanding prevalence is causing it to develop into a major global health concern. NAFLD is closely linked to the modern, unhealthy lifestyle. The Western diet, characterized by excessive energy intake, frequent consumption of red meat, processed meat and foods, soft drinks, and sugar-sweetened beverages (SSBs), irregular meal distribution throughout the day, and unhealthy ways of cooking, predisposes to development of NAFLD. Low levels of physical activity and prolonged sedentary time are additional lifestyle risk factors for NAFLD. Given the present lack of effective pharmacological treatment, lifestyle modifications are regarded as the cornerstone of NAFLD management. Reducing daily calorie intake together with following the Mediterranean diet (MD) is an increasingly accepted approach. Furthermore, increasing the level of physical activity and limiting sedentary behavior are additional measures proposed to improve the outcomes of the disease. Apart from being affected by lifestyle, NAFLD may also affect patients' quality of life (QoL), mostly in the domain of physical function. In this regard, while the early and more benign form of the disease, i.e., simple hepatic steatosis, may not affect QoL, there is evidence, though conflicting, of the impact of nonalcoholic steatohepatitis (NASH) on this index, with, however, most studies showing that QoL is consistently affected in advanced disease, i.e., hepatic fibrosis, cirrhosis, and hepatocellular carcinoma. Considering all the above, appropriate management of lifestyle is likely to attenuate the severity of the disease and improve the QoL of NAFLD patients.

摘要

非酒精性脂肪性肝病(NAFLD)是一种代谢紊乱性疾病,其目前迅速扩大的流行率使其成为一个主要的全球健康关注点。NAFLD 与现代不健康的生活方式密切相关。西方饮食的特点是能量摄入过多、频繁食用红肉、加工肉和食品、软饮料和含糖饮料(SSBs)、一天中不规律的进餐时间以及不健康的烹饪方式,这些都容易导致 NAFLD 的发生。低水平的身体活动和长时间的久坐也是 NAFLD 的另外两个生活方式风险因素。鉴于目前缺乏有效的药物治疗方法,生活方式的改变被认为是 NAFLD 管理的基石。减少每日热量摄入并遵循地中海饮食(MD)是一种越来越被接受的方法。此外,增加身体活动水平和限制久坐行为是另外两种被提议的改善疾病结局的措施。除了受到生活方式的影响,NAFLD 还可能影响患者的生活质量(QoL),主要是在身体功能方面。在这方面,尽管疾病的早期和更良性形式,即单纯性肝脂肪变性,可能不会影响 QoL,但有证据表明,非酒精性脂肪性肝炎(NASH)对这一指标有影响,尽管存在冲突,但大多数研究表明,在晚期疾病(即肝纤维化、肝硬化和肝细胞癌)中,QoL 始终受到影响。考虑到上述所有因素,适当的生活方式管理可能会减轻疾病的严重程度并改善 NAFLD 患者的生活质量。

相似文献

1
Nonalcoholic fatty liver disease: lifestyle and quality of life.非酒精性脂肪性肝病:生活方式和生活质量。
Hormones (Athens). 2022 Mar;21(1):41-49. doi: 10.1007/s42000-021-00339-6. Epub 2021 Dec 1.
2
[Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management].[非酒精性脂肪性肝病/非酒精性脂肪性肝炎管理概述]
Yakugaku Zasshi. 2019;139(9):1147-1153. doi: 10.1248/yakushi.19-00011-1.
3
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
4
The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.美国生活方式引起的肥胖综合征饮食在雄性和雌性啮齿动物中再现了非酒精性脂肪性肝病和非酒精性脂肪性肝炎的临床和转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2020 Sep 1;319(3):G345-G360. doi: 10.1152/ajpgi.00055.2020. Epub 2020 Aug 5.
5
Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease.生活方式干预对非酒精性脂肪性肝病发病机制的影响。
World J Gastroenterol. 2024 May 28;30(20):2633-2637. doi: 10.3748/wjg.v30.i20.2633.
6
Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments.非酒精性脂肪性肝炎(NASH)——当前的治疗建议及未来发展
Z Gastroenterol. 2019 Apr;57(4):508-517. doi: 10.1055/a-0784-8827. Epub 2019 Apr 9.
7
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.生活方式干预治疗病态肥胖:对肝脏脂肪变性、炎症和纤维化的影响。
Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G329-G338. doi: 10.1152/ajpgi.00044.2018. Epub 2018 Jun 7.
8
New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis.非酒精性脂肪性肝病的新治疗策略:关注非酒精性脂肪性肝炎的有前途药物。
Pharmacol Rep. 2020 Feb;72(1):1-12. doi: 10.1007/s43440-019-00020-1. Epub 2020 Jan 8.
9
Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的流行病学与自然史
Semin Liver Dis. 2015 Aug;35(3):221-35. doi: 10.1055/s-0035-1562943. Epub 2015 Sep 17.
10
Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.非酒精性脂肪性肝病(NAFLD)中的营养与身体活动:流行病学证据概述。
World J Gastroenterol. 2011 Aug 7;17(29):3377-89. doi: 10.3748/wjg.v17.i29.3377.

引用本文的文献

1
Intake of S-Methylmethionine Alters Glucose Metabolism and Hepatic Gene Expression in C57BL/6J High-Fat-Fed Mice.S-甲基蛋氨酸的摄入改变高脂喂养的C57BL/6J小鼠的葡萄糖代谢和肝脏基因表达。
Foods. 2024 Dec 26;14(1):34. doi: 10.3390/foods14010034.
2
Circulating lipoprotein(a) in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.非酒精性脂肪性肝病患者循环脂蛋白(a):一项系统评价和荟萃分析。
J Gastroenterol Hepatol. 2024 Dec;39(12):2572-2581. doi: 10.1111/jgh.16768. Epub 2024 Oct 17.
3
Clinical Characteristics of Sarcopenia in Nonalcoholic Fatty Liver Disease: A Systemic Scoping Review.

本文引用的文献

1
The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?常量营养素摄入对非酒精性脂肪性肝病(NAFLD)的影响:脂肪过多、碳水化合物过多,还是仅仅热量过多?
Front Nutr. 2021 Feb 16;8:640557. doi: 10.3389/fnut.2021.640557. eCollection 2021.
2
Higher Healthy Lifestyle Score is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and older Chinese adults: a community-based cross-sectional study.更高的健康生活方式评分与中年及以上中国成年人中非酒精性脂肪肝的低患病率相关:一项基于社区的横断面研究。
Public Health Nutr. 2021 Oct;24(15):5081-5089. doi: 10.1017/S1368980021000902. Epub 2021 Feb 26.
3
非酒精性脂肪性肝病中肌肉减少症的临床特征:一项系统性综述。
Obes Facts. 2025;18(1):72-85. doi: 10.1159/000541650. Epub 2024 Oct 16.
4
Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine.肠道微生物、饮食和遗传作为代谢性肝病的驱动因素:一篇综述性叙述,概述了对精准医学的影响。
J Nutr Biochem. 2024 Nov;133:109704. doi: 10.1016/j.jnutbio.2024.109704. Epub 2024 Jul 17.
5
Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives.靶向慢性肝脏疾病:分子标志物、药物传递策略和未来展望。
Int J Pharm. 2024 Jul 20;660:124381. doi: 10.1016/j.ijpharm.2024.124381. Epub 2024 Jun 23.
6
Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis.儿童和青少年非酒精性脂肪性肝病的患病率:系统评价和荟萃分析。
World J Pediatr. 2024 Jun;20(6):569-580. doi: 10.1007/s12519-024-00814-1. Epub 2024 May 21.
7
Hypogonadism and nonalcoholic fatty liver disease.性腺功能减退症与非酒精性脂肪性肝病。
Endocrine. 2024 Oct;86(1):28-47. doi: 10.1007/s12020-024-03878-1. Epub 2024 May 21.
8
Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR).尼古丁联合可口可乐™导致的肝脂肪变性可被烟酰胺核糖(NR)所预防。
Front Endocrinol (Lausanne). 2024 May 2;15:1282231. doi: 10.3389/fendo.2024.1282231. eCollection 2024.
9
Partial validation of a six-month high-fat diet and fructose-glucose drink combination as a mouse model of nonalcoholic fatty liver disease.六个月高脂肪饮食和果糖-葡萄糖饮料联合应用于非酒精性脂肪肝疾病小鼠模型的部分验证。
Endocrine. 2024 Aug;85(2):704-716. doi: 10.1007/s12020-024-03769-5. Epub 2024 Mar 20.
10
Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease.关于胰高血糖素样肽-1 受体激动剂和相关多激动剂在非酒精性脂肪性肝病中的动物研究。
Hormones (Athens). 2024 Dec;23(4):611-619. doi: 10.1007/s42000-024-00541-2. Epub 2024 Mar 12.
Effect of dietary carbohydrate and lipid modification on clinical and anthropometric parameters in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
饮食碳水化合物和脂质改良对非酒精性脂肪性肝病临床和人体测量参数的影响:系统评价和荟萃分析。
Nutr Rev. 2021 Nov 10;79(12):1321-1337. doi: 10.1093/nutrit/nuaa146.
4
Major Histocompatibility Complex Class I-Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver Disease.主要组织相容性复合体 I 类相关链 A 等位基因与非酒精性脂肪性肝病的组织学。
Hepatol Commun. 2020 Sep 30;5(1):63-73. doi: 10.1002/hep4.1610. eCollection 2021 Jan.
5
Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的流行病学、发病机制、诊断和新兴治疗方法。
Arch Med Res. 2021 Jan;52(1):25-37. doi: 10.1016/j.arcmed.2020.11.010. Epub 2020 Dec 14.
6
Lewis score on capsule endoscopy can predict the prognosis in patients with small bowel lesions of Crohn's disease.胶囊内镜下 Lewis 评分可预测克罗恩病小肠病变患者的预后。
J Gastroenterol Hepatol. 2021 Jul;36(7):1851-1858. doi: 10.1111/jgh.15366. Epub 2020 Dec 22.
7
Relationship between dietary patterns and non-alcoholic fatty liver disease: A systematic review and meta-analysis.饮食模式与非酒精性脂肪性肝病的关系:系统评价和荟萃分析。
J Gastroenterol Hepatol. 2021 Jun;36(6):1470-1478. doi: 10.1111/jgh.15363. Epub 2020 Dec 14.
8
Health related quality of life in chronic liver diseases.慢性肝病患者与健康相关的生活质量
Liver Int. 2020 Nov;40(11):2630-2642. doi: 10.1111/liv.14647.
9
Effect of exercise on hepatic steatosis: Are benefits seen without dietary intervention? A systematic review and meta-analysis.运动对肝脂肪变性的影响:在没有饮食干预的情况下是否能看到益处?系统评价和荟萃分析。
J Diabetes. 2021 Jan;13(1):63-77. doi: 10.1111/1753-0407.13086. Epub 2020 Aug 11.
10
Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations.非酒精性脂肪性肝病患者的地中海饮食:观察性和临床研究的系统评价与荟萃分析
J Diabetes Metab Disord. 2020 Feb 17;19(1):575-584. doi: 10.1007/s40200-019-00475-2. eCollection 2020 Jun.